Iwata H - Search Results

1

Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).

Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: iwata h. Cancer Sci. 2022 Sep;113(9):3169-3179. doi: 10.1111/cas.15474. Epub 2022 Jul 23. Cancer Sci. 2022. PMID: 35754298 Free PMC article. Clinical Trial.

2

Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.

Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S. Iwase H, et al. Among authors: iwata h. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S34-8. doi: 10.1007/s00280-003-0592-1. Epub 2003 Jun 19. Cancer Chemother Pharmacol. 2003. PMID: 12819932

3

Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women.

Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima K. Hirose K, et al. Among authors: iwata h. Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):239-46. Asian Pac J Cancer Prev. 2003. PMID: 14507245 Free article.

4

The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.

Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K. Hirose K, et al. Among authors: iwata h. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1407-11. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298966

5

Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.

Yamashita T, Yamashita H, Itoh Y, Karamatsu S, Itoh K, Hara Y, Ando Y, Sugiura H, Kuzushima T, Toyama T, Iwata H, Kobayashi S, Iwase H. Yamashita T, et al. Among authors: iwata h. Breast Cancer. 2006;13(4):334-9. doi: 10.2325/jbcs.13.334. Breast Cancer. 2006. PMID: 17146158 Free article. Clinical Trial.

6

Perspective of trastuzumab treatment.

Iwata H. Iwata H. Breast Cancer. 2007;14(2):150-5. doi: 10.2325/jbcs.955. Breast Cancer. 2007. PMID: 17485899 Free article. Review.

7

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.

Toyama T, Zhang Z, Nishio M, Hamaguchi M, Kondo N, Iwase H, Iwata H, Takahashi S, Yamashita H, Fujii Y. Toyama T, et al. Among authors: iwata h. Breast Cancer Res. 2007;9(3):R34. doi: 10.1186/bcr1682. Breast Cancer Res. 2007. PMID: 17537232 Free PMC article.

8

Dietary patterns and the risk of breast cancer in Japanese women.

Hirose K, Matsuo K, Iwata H, Tajima K. Hirose K, et al. Among authors: iwata h. Cancer Sci. 2007 Sep;98(9):1431-8. doi: 10.1111/j.1349-7006.2007.00540.x. Epub 2007 Jul 11. Cancer Sci. 2007. PMID: 17627618 Free article.

9

A case of invasive micropapillary carcinoma of the breast.

Ota D, Toyama T, Ichihara S, Mizutani M, Kamei K, Iwata H. Ota D, et al. Among authors: iwata h. Breast Cancer. 2007;14(3):323-6. doi: 10.2325/jbcs.14.323. Breast Cancer. 2007. PMID: 17690513 Free article.

10

[Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)].

Masuda N, Toi M, Takatsuka Y, Nakamura S, Iwata H, Ohno S, Kuroi K, Kusama M, Hisamatsu K, Yamazaki K, Eisei S, Sato Y, Kaise H, Kashiwaba M, Iwase H, Kurosumi M, Tsuda H, Akiyama F; Japan Breast Cancer Research Group. Masuda N, et al. Among authors: iwata h. Gan To Kagaku Ryoho. 2007 Oct;34(10):1609-15. Gan To Kagaku Ryoho. 2007. PMID: 17940375 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,966 results

Search Page